KPC(SH:600422) Zheng Quan Zhi Xing·2025-06-24 17:18Summary of Key Points Core Viewpoint - The announcement details the progress of external guarantees provided by Kunming Pharmaceutical Group Co., Ltd. to its subsidiaries, emphasizing the financial support for their operational needs in 2025 and the associated risks due to high debt levels of the guaranteed companies [1][6]. Group 1: Guarantee Details - The total guarantee amount provided to the subsidiaries is RMB 12.5 million, with a cumulative guarantee balance of RMB 33.7 million [1]. - The guaranteed companies, Qujing Kangqiao Pharmaceutical Co., Ltd. and Kunming Commercial (Zhaotong) Pharmaceutical Co., Ltd., are both subsidiaries of Kunming Pharmaceutical Group [1][2]. - There are no collateral guarantees associated with this external guarantee [1]. Group 2: Financial Status of Guaranteed Companies - Qujing Kangqiao has an asset-liability ratio of 73.60% as of March 31, 2025, indicating a high level of debt [2]. - Kunming Commercial (Zhaotong) has an asset-liability ratio of 86.07% as of March 31, 2025, also reflecting significant financial leverage [2]. - Both companies are not classified as dishonest executors, and their credit status is reported as good [2]. Group 3: Board of Directors' Opinion - The board believes that the guarantees are necessary to support the subsidiaries' operational needs, enhance financing efficiency, and lower financing costs [6]. - The board has assessed the financial stability and operational conditions of the guaranteed companies, concluding that the overall risk is manageable [6]. Group 4: Cumulative Guarantee Information - As of the announcement date, the total external guarantee balance of the company and its subsidiaries is RMB 113.85 million, which is 2.17% of the latest audited net assets [7]. - The total guarantee amount provided to subsidiaries is RMB 456.15 million, representing 8.68% of the latest audited net assets [7].